Dynavax to Present at William Blair & Company's 2011 Life Sciences Conference
BERKELEY, CA, Sep 01, 2011 (MARKETWIRE via COMTEX) -- Dynavax Technologies
Corporation (DVAX) announced today that it plans to present at William Blair &
Company's 2011 Life Sciences Conference in New York on Wednesday, September 7,
2011 at 2:40 pm EDT (11:40 am PDT).
Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate
overview presentation. To access the live webcast and the subsequent archived
recording of the presentation, please log onto Dynavax's website at
investors.dynavax.com.
About Dynavax
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company,
discovers and develops novel products to prevent and treat infectious and
inflammatory diseases. The Company's lead product candidate is HEPLISAV(TM), a
Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and
superior protection with fewer doses than current licensed vaccines. For more
information visit dynavax.com. |
